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SubtilomycinBacillus subtilisOH131.1 is a bacterial antagonist of Fusarium graminearum, a plant pathogenwhich causes Fusar-
ium head blight in wheat. The genome of B. subtilis OH 131.1 was sequenced, annotated and analyzed to under-
stand its potential to produce bioactive metabolites. The analysis identiﬁed 6 synthetic clusters for metabolites
that could impact biocontrol efﬁcacy. Five of the clusters were conﬁrmed functional with HPLC–MS/MS of the
culture supernatant. The analysis also provided the data to determine the phylogeny of the subject strain. The
phylogeny results characterize the strain as B. subtilis subsp. subtilis. Comparative genomicswas used to compare
the genome of B. subtilisOH131.1with closely related strains. Previously, the culture supernatant of B. subtilisOH
131.1 showed no antifungal activity, which suggested that itmay be a suitable candidate to combinewith a yeast
antagonist (Cryptococcus ﬂavescens OH 182.9) of Fusarium head blight for possible enhanced biocontrol efﬁcacy.
Co-cultures of B. subtilis OH 131.1 and C. ﬂavescens OH 182.9 were produced with varying ratios of the starting
inoculum of the two strains. The strains alone and the various ratios were evaluated for biocontrol activity in
greenhouse assays. Co-cultures of B. subtilis OH 131.1 and C. ﬂavescens OH 182.9 initially inoculated at a ratio
of 1:100 or 1:10, respectively, were the most effective in reducing disease symptoms compared to the control.
The most effective co-cultures were not statistically more efﬁcacious than individual strains. This study reports
the ﬁrst co-culturing of bacterial and yeast biocontrol antagonists and their efﬁcacy in greenhouse assays.. Dunlap).
ll rights re© 2015 The Authors. Published by Elsevier B.V. All rights reserved. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
A large variety of bacteria and fungi that can antagonize plant
pathogens has been identiﬁed. These microbes utilize a wide variety
of modes-of-action to inhibit plant pathogens (Santoyo et al., 2012).
Such observations have prompted several researchers to explore
mixtures of strains for possible improved biocontrol consistency and
efﬁcacy (Pierson and Weller, 1994; de Boer et al., 1999; Guetsky et al.,
2001; Schisler et al., 2005; Slininger et al., 2010). While many mixtures
showed improved efﬁcacy, some have resulted in a decrease in biocon-
trol efﬁcacy compared to component strains tested individually
(Vanneste and Yu, 1996; Stockwell et al., 2010). In these cases, the
mode-of-action of the component strains may be incompatible and re-
sults in some mixtures exhibiting less than expected levels of efﬁcacy
in reducing disease (Stockwell et al., 2011).
The use of a combination of strains also generates additional logistic
considerations, such as, should component strains be produced inde-
pendently and combined or can they be cultured together; the latter
approach having been only recently reported in the biological controlserved. This is anopenaccesliterature (Slininger et al., 2010; Schisler et al., 2011). Capital costs for
producing a single co-cultured product would likely be less than costs
associated withmixing two or more independently producedmicrobial
products given the savings in development, production and formulation
of biomass, registration and quality control costs for the co-cultured
product (Slininger et al., 2010). In the biological control of post-
harvest maladies on potatoes, a co-cultured product containing three
different isolates of Pseudomonas ﬂuorescens provided greater control
than a mixture of the same three strains produced separately demon-
strating an additional potential advantage of co-culturing strains
(Slininger et al., 2010). Whether co-cultures of microbial strains from
different taxonomic Kingdoms can be consistently produced and
whether such co-cultures would have efﬁcacy in reducing a plant
disease have not been reported.
Our laboratory has previously identiﬁed severalmicrobes that inhib-
it plant pathogens. These include, Cryptococcus ﬂavescens (formerly
Cryptococcus nodaensis) OH 182.9 (NRRL Y-30216), which is a basidio-
mycetous yeast that reduces Fusarium head blight (FHB) in greenhouse
and ﬁeld studies on wheat (Schisler et al., 2002b; Khan et al., 2004). A
fungicide tolerant variant of this strain also reduces FHB (Schisler and
Boehm, 2012) and was used in this study. C. ﬂavescens is thought to in-
hibit the primary causal agent of FHB on wheat in North America,s article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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tive exclusion (Schisler et al., 2014), since no antifungal activity has
been observed in culture supernatant or direct competition assays
(Schisler, unpublished). In addition, Bacillus subtilis OH 131.1, a gram-
positive bacterium was isolated as a potential antagonist of FHB (Khan
et al., 2001). This strain was originally isolated from newly emerged
anthers of ﬁeld grown winter wheat and was subsequently shown to
be effective in reducing FHB incidence and severity in wheat (Khan
et al., 2001; Schisler et al., 2002a, 2002b; Khan et al., 2004). B. subtilis
OH 131.1 does not produce antifungal compounds in culture superna-
tant or exhibit antibiosis of G. zeae in direct competition assays
(Dunlap et al., 2011). The lack of antifungal compounds suggests that
B. subtilis OH 131.1 maybe a compatible candidate for co-culturing
with C. ﬂavescens OH 182.9 to produce a biocontrol product with
enhanced efﬁcacy.
The goal of the current study was to sequence, assemble, and anno-
tate the genome of B. subtilis OH 131.1 and subsequently determine its
potential to produce secondary metabolites that impart desirable bio-
control activities (e.g., the production of antifungal compounds) or im-
pact the ability of the strain to grow in co-culture with C. ﬂavescens OH
182.9. The genomic datawill then beused to conduct phylogenetic anal-
ysis of the strain. An additional goalwas to assess the ability of B. subtilis
OH 131.1 to be co-cultured with the yeast C. ﬂavescens OH 182.9 and to
determine the biocontrol efﬁcacy of the co-cultured product against
FHB in a greenhouse study.
2. Material and methods
2.1. Strain culturing
B. subtilis strain OH 131.1 was obtained from the ARS (NRRL) Patent
Culture Collection (http://nrrl.ncaur.usda.gov) as NRRL B-30212. The
strain was subsequently produced in a semi-deﬁned complete liquid
culture medium (SDCL) (Slininger et al., 2007) for all assays. Samples
of bacterial cultures frozen at −80 °C in 10% glycerol were streaked
for purity onto one-ﬁfth strength tryptic soy broth agar (TSBA/5),
pH 6.8 (Difco Laboratories, Detroit, MI). After 24 h incubation at 28 °C,
cells were removed from the surface of colonized plates using sterile
cotton swabs and utilized to initiate liquid starter cultures of the strain.
Ten milliliters of SDCL in 50ml Erlenmeyer ﬂasks were inoculated to an
optical density of approximately 0.2 at 620 nmwavelength light (A620)
for liquid starter cultures. The starter cultures were then incubated in a
shaker incubator (Innova 4230, New Brunswick Scientiﬁc, Edison, NJ) at
25 °Cwith a throwof 2.5 cmand 250 rpm for 24h. Afterwards, the start-
er cultures were used to inoculate liquid test cultures composed of
50 ml of SDCL in 250 ml Erlenmeyer ﬂasks to an optical density of 0.1
(A620). Test cultures were incubated as described for liquid starter cul-
tures and harvested at 9, 12, 24, and 48 h of culture growth as needed
for conducting analyses and bioassays.
2.2. Genome sequencing
B. subtilis strain OH 131.1 was cultured as described above to early
stationary phase (~24 h) and harvested by centrifugation. DNA extrac-
tion was performed on the pelleted bacterial biomass using the
Epicentre Masterpure DNA Puriﬁcation kit (Illumina Inc., Madison,
WI). The total genomic DNA extraction was subsequently fragmented
to 200 bp and size-selected using an E-gel apparatus (Life Technologies
Inc., Grand Island, NY). Sequencing adapters were ligated using an Ion
Express™ Plus Fragment Library kit (Life Technologies Inc., Grand
Island, NY). Emulsion PCR to incorporate the DNA fragment library to
the sequencing beads was performed using the Ion OneTouch™ instru-
ment with an Ion OneTouch™ System Template kit (Life Technologies
Inc., Grand Island, NY). The library sample was ﬁnally sequenced on
an Ion Torrent Personal Genome Machine using an Ion 316 chip and
the Ion PGM™ 200 sequencing kit (Life Technologies Inc., Grand Island,NY) following the manufacturer's suggested protocols. The resulting
reads were quality trimmed to the Q20 conﬁdence level. The genome
was assembled using both CLCbio 6.1 (Qiagen Inc., Cambridge, MA)
and SeqMan NGen® 4.1 (DNAstar Inc., Madison, WI) using default pa-
rameters. The gaps were closed using primer walking with standard
PCR. The sequence was deposited in NCBI GenBank under accession
number CP007409.
2.3. Culture production and sample preparation of secondary metabolites
B. subtilis strain OH 131.1 was cultured as described above and the
culture supernatant was collected during the exponential growth
phase (9 h and 12 h), early stationary phase (24 h) and late stationary
phase (48 h). The cells were removed by centrifugation, and the cell-
free supernatant was partitioned into fractions using a C18 syringe
cartridge (Maxi-clean SPE 300 mg C18, Grace Inc., Deerﬁeld, IL). Four
milliliters of cell-free supernatant was loaded on to the cartridge and
washed with 5 ml of water, then two fractions were eluted using 1 ml
of 70% and 100% methanol. In addition to the above method, a second
method was utilized after initial attempts to identify subtilomycin
were unsuccessful. This method was based on a previous method used
to isolate subtilomycin (Phelan et al., 2013). Brieﬂy, 25 ml of superna-
tant was precipitatedwith ammonium sulfate in steps of 10% saturation
up to 40% at 4 °C. The precipitate from the 40% saturation step was col-
lected by centrifugation at 16,000 g for 20min and decanting the super-
natant. The precipitate was resuspended in 1 ml HPLC grade water and
analyzed using RP-LC–MS/MS.
2.4. Reverse-phase liquid chromatography tandem mass spectrometry
(RP-LC–MS/MS)
The C18 fractionated supernatant mixtures from above were ana-
lyzed by RP-LC–MS/MS (20 μl injections; Agilent 1100 HPLC, equipped
with a PDA monitoring at λ 280 nm) through a C18 column
(3.0mm× 15 cm, 3 μmparticle size; Inertsil, GL Sciences, Inc., Torrance,
CA) running a gradient elution of 95% A:5% B (buffer A 0.1% formic acid,
buffer B 100% acetonitrile) to 5% A:95% B over 60 min at a ﬂow rate of
300 μl/min, followed by a 5 minute B washout and 15 minute re-
equilibration, while maintaining a constant column temperature of
30 °C. Electrospray positive mode ionization data were collected with
a Q-oTOF (quadrupole-orthogonal time-of-ﬂight) mass spectrometer
(Applied Biosystems/MDS Sciex Qstar/Elite) via turbo spray ionization
in the positive mode. Fragmentation data was attained using collision
energy (CAD = 5, CE = 45). Fragmentation energies were held at a
level that maintained a large percentage of the parent ion peak in
order to minimize the generation of secondary fragments. Tandem
mass spectra were collected isolating the 2+ charge state for subtilosin
and 3+ charge state for subtilomycin, as these were the most abundant
charge states.
2.5. Phylogenetic analysis
In order to determine the taxonomic afﬁliation of strain OH 131.1,
the phylogenetic framework developed by Rooney et al. (2009) for the
B. subtilis species complex was used. The dataset encompasses a concat-
enation (5550 bp) of six genes including 928 bp from gyrA, 964 bp from
rpoB, 875 bp from purH, 777 bp from polC, 835 bp from groEL, and
1171 bp from 16S rRNA taken from strains deposited in the ARS Culture
Collection (http://nrrl.ncaur.usda.gov). The homologous sequence data
from strain OH 131.1 was added to this dataset, alongwith correspond-
ing sequence data from strains QB928 (Yu et al., 2012) and BSn5 (Deng
et al., 2011). Phylogenetic analyses of gene sequence data were con-
ducted using the neighbor-joining (NJ) method (Saitou and Nei,
1987). The computer program MEGA 6.06 (Kumar et al., 2004;
Tamura et al., 2013) was used to reconstruct NJ trees from Tamura–
Nei gamma distances (Tamura and Nei, 1993). The gamma shape
Table 1
Genome statistics of B. subtilis subsp. subtilis OH 131.1.
Size 4,039,155 bp
Number of genes 4061
Number of proteins 3885
tRNAs 80
rRNAs 24
GC% 43.85%
Average coverage 49×
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reliability of internal branches was assessed from 1500 bootstrap
pseudoreplicates.
2.6. Bioinformatics and comparative genomics
The determination of open reading frames (ORFs) and annotation
was carried out using both RAST server (Aziz et al., 2008) and NCBI Pro-
karyotic Genomes Automatic Annotation Pipeline (PGAAP) (Angiuoli
et al., 2008). The annotations were manually reﬁned by direct compar-
ison to closely related completed genomes. The comparative genomics
and core genome analysis was performed using CMG-Biotools (Vesth
et al., 2013). To simplify comparisons, automated gene prediction was
performed on all of the genomes using Prodigal (Hyatt et al., 2010), to
eliminate differences in gene calling. Strains and GenBank ﬁles used
in comparisons were: B. subtilis subsp. subtilis str. BSn5 (CP002468),
B. subtilis subsp. subtilis str. QB946 (CP003783), B. subtilis subsp. subtilis
str. 168 (AL009126), B. subtilis subsp. spizizenii str. W23 (CP002183),
B. subtilis subsp. inaquosorum KCTC 13429 (AMXN01000001–
AMXN01000024) and Bacillus amyloliquefaciens subsp. plantarum str.
FZB42 (CP000560). In the proteome comparisons, homologs and
paralogs were based on 50% homology with 50% coverage.
2.7. Co-culture of B. subtilis OH 131.1 and C. ﬂavescens OH 182.9 3C
Cultures of C. ﬂavescens OH 182.9 3C (NRRL Y-30216) and B. subtilis
OH 131.1 were initiated on 1/5 strength tryptic soy broth agar (TSBA,
Difco Laboratories, Detroit, MI) from 10% glycerol stocks of the strains
stored at−80 °C. Twenty-four hour liquid starter cultures of each strain
were produced as described earlier and used to inoculate liquid test cul-
tures composed of 50ml of SDCL in 250ml Erlenmeyer ﬂasks. A total of
1 ml of starter inoculum was used to inoculate two starter cultures per
treatment. The starter inoculumusedwere OH131.1 alone, OH 182.9 3C
alone, and various ratios of the two strains including 1:100, 1:10, 1:1,
10:1, and 100:1 respectively. Flask cultureswere incubated as described
earlier and harvested at 48 h, and colony forming units (cfu) per ml of
OH 131.1 and OH 182.9 were determined by serial dilution onto TSBA/
5 and TSBA/5 + 100 ppm streptomycin, respectively. The experiment
was conducted three times. Harvested cultures were used at 25% full
strength for tests of biocontrol efﬁcacy against FHB on wheat.
2.8. Efﬁcacy of co-cultured inoculum against Fusarium head blight in a
greenhouse bioassay
Wheat plant production and bioassays against FHB were as de-
scribed previously (Schisler et al., 2011) with minor exceptions. Brieﬂy,
wheat plants (hard red spring cultivar Norm)were grown 3 per 19-cm-
diameter plastic containing air-steam pasteurized (60 °C for 30 min)
potting mix (Terra-lite Redi-earth mix, W.R. Grace, Cambridge, MA).
Plants were grown in a growth chamber (23 °C day, 18 °C night, 14-h
photoperiod, 600 μmol/[m2/s]) for 6–8weeks prior to transfer to green-
house benches. Experiments to determine the efﬁcacy of co-cultures
and the individual microbial strains were conducted in a climate-
controlled greenhouse. Conidial inoculum of G. zeae Z-3639 was
produced on clariﬁed V8 juice agar (CV8 agar) in Petri plates under a re-
gime of 12 h/day ﬂuorescent light for seven days at 24 °C. Conidia were
then harvested from plates ﬂooded with a weak PO4 buffer (Schisler
et al., 2014) to obtain conidial suspensions of the pathogen (Schisler
et al., 2002b). Approximately one week after transferring plants to the
greenhouse, wheat heads were inoculated after plants had entered an-
thesis (Feekes 10.5.1, (Large, 1954)) by spraying 25% freshly harvested,
48 h liquid test cultures of individual antagonist strains and co-cultures
PO4 buffer and a ﬁnal concentration of 0.036% Tween 80 (Sigma
Chemical Co., St. Louis, MO). Antagonist cells were applied in the
greenhouse at a ﬁeld equivalent rate of approximating 375 l/ha. For
each treatment application, 40 ml of 25% test culture was used to treatsix plants representing a total of 12 to 16 heads. Heads were then
challenged immediately by spraying 12 ml of a conidial suspension of
G. zeae (2.5 × 104 conidia/ml) in PO4 buffer with 0.036% Tween® 80.
Wheat heads treated with buffer and Tween® 80 only, followed by a
suspension of G. zeae served as a disease control and untreated pots
were used to insure pathogen inoculum was not spreading between
treatments. Treated plants were misted lightly with distilled water
and incubated in a plastic humidity chamber at 17 °C to 20 °C at night
and 25 °C to 28 °C during the day for 3 days before being transferred
to greenhouse benches. Treatments were arranged in a completely
randomized design. Fusarium head blight severity was visually
estimated using a 0 to 100% scale (Stack and McMullen, 1995) at
16 days after inoculation when disease symptoms had reached a
maximum value. All greenhouse experiments were conducted 3 times.
Disease severity data from repeated experiments were combined and
analyzed using one-way analysis of variance (ANOVA) after preliminary
analysis revealed that experiment by treatment interactions was not
signiﬁcant (P ≤ 0.05). Means were separated using Fisher's protected
LSD test (FPLSD, P ≤ 0.05).
3. Results
3.1. B. subtilis strain OH 131.1 genome sequencing
B. subtilis strain OH 131.1 was sequenced to an average coverage
depth of 49×. The assembly and subsequent gap closure yielded one
scaffold with a length of 4,039,155 bp. A summary of the results is pro-
vided in Table 1. Potential secondary metabolite clusters were screened
using an automated genome mining algorithm, antiSMASH (Medema
et al., 2011) or direct searching with BLAST for gene clusters known
to be present in B. subtilis strains. The automated genome mining
algorithmwas useful in identifying the two common types of secondary
metabolite gene clusters, non-ribosomal peptide synthetases and poly-
ketide synthases. A summary of the gene clusters identiﬁed is provided
in Table 2. The results identify four potential antifungal compounds,
surfactin, plipastatin, subtilomycin and subtilosin. In addition, it identi-
ﬁed two other compounds that could impact biocontrol efﬁcacy; a
siderophore (bacillibactin), and an antibacterial (bacillaene). In addition
to these synthetic clusters, a 31 kD protein (TasA) with reported anti-
bacterial activity was found (Stöver and Driks, 1999) and the ytpA pro-
teinwhichwas reported to synthesize bacilysocin, a phospholipid based
antibiotic (Tamehiro et al., 2002).
3.2. HPLC–MS/MS
To conﬁrm that the synthetic clusters were functional, we screened
culture supernatants during different growth stages for the presence
of the metabolites. We screened samples from the exponential growth
phase, early stationary phase and the late stationary phase. The results
show that subtilosin (3399 Da, Fig. 1) (Kawulka et al., 2004) was pro-
duced in signiﬁcant amounts and increases with culture time and was
one of the most prominent metabolites produced. Subtilosin ion frag-
mentation occurred primarily in the proline-containing macrocyclic
ring and the adjacent larger alanine- and glycine-rich macrocycle. Due
to the high number of glycine and alanine components of the ring,
Table 2
Secondary metabolite synthetase clusters in B. subtilis OH 131.1.
Compound Synthetase type Genes Size (kb) Location
Surfactin NRPS srfAA,AB,AC,AD 26.1 364980…391127
Plipastatin NRPS ppsA,B,C,D,E 34.1 1988046…1953885
Bacillibactin NRPS besA,dhbA,C,E,B,F 12.8 3093546…3106386
Bacillaene PKS baeB,C,D,E,acpK baeG,H,I,J,L,M,N,R,S 77.0 1725401…1802496
Subtilomycin Lantibiotic subA,P,B,C,I,T 8.1 203076…211144
Subtilosin Bacteriocin sboA, sboX, albA,B,C,D,E,F,G 6.9 3657524…3664461
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are used to indicate the positions where fragmentation was observed.
The two lipopeptides, surfactin and plipastatin, as well as siderophore
bacillibactin, were observed in small amounts, while bacillaene was
not detected under these growth conditions. Subtilomycin (3234 Da,
Fig. 1) (Phelan et al., 2013)was observed during the exponential growth
phase (9 and 12 h), followed by a diminishing signal during the station-
ary phase (24 and 48 h). Tandemmass spectra of subtilomycin yielded a
small number of fragments due to the cyclic components of the
lantibiotic class; however fragments containing the N-terminus were
observed, as indicated by arrows in Fig. 1. Speciﬁcally, the N-terminal
2-oxobutyrate with the adjacent tryptophan (271.08); its adjacent ala
(342.19); then fragmenting at the 4th (Ile) residue (538.32); 7th
(Abu) residue (806.54); and the 14th (Arg) residue (1404.12) are con-
sistent with the subtilomycin structure. The ammonium sulfate precip-
itation used to isolate the products led to ammonium adducts of the
products being observed in the mass spectra; tandem mass spectra of
these peaks contained almost exclusively the neutral loss of ammonia
without informative fragmentation.3.3. Phylogenetic analysis
The phylogenetic placement of OH 131.1 is shown in Fig. 2. The
strain is amember of the B. subtilis subsp. subtilis clade and closely relat-
ed to three strains (NRRL BD-586, NRRL BD-587 and NRRL BD-588)
isolated from soil collected in Greenland and a strain (NRRL BD-566)Fig. 1.A) Subtilosin at 48 h. EIC blue 2+ ion, red 3+ ion. Brackets indicate locations of ion fragme
impurity peak). Arrows indicate locations of ion fragmentations.isolated from sand collected in Ghana (isolate source data obtained
from the ARS Culture Collection database).
3.4. Comparison to related strains
The genome of B. subtilis subsp. subtilisOH131.1 had two large addi-
tions (N10 kbp) not found in closely related strains (B. subtilis subsp.
subtilis 168, B. subtilis subsp. subtilis BSn5, and B. subtilis subsp. subtilis
QB946). Both were identiﬁed as prophages and identiﬁed using phage
searching software (Zhou et al., 2011). The ﬁrst was identiﬁed as a
complete intact prophage spanning 37.4 kb at position (1258892…
1296305). The second was questionable on completeness and spanned
62.9 kb at position (18163370…1879343). The genome of B. subtilis
subsp. subtilis OH 131.1 had two deletions of known antibiotics that
are found in their close relatives, sublancin (Paik et al., 1998) and
subtilin (Klein et al., 1992).
The protein-coding regions of B. subtilis subsp. subtilis OH 131.1, a
closely related biocontrol strain (B. subtilis subsp. subtilisBSn5), a closely
related strain with the complete genome available (B. subtilis subsp.
subtilisQB946), theB. subtilis subsp. type strains (B. subtilis subsp. subtilis
168, B. subtilis subsp. spizizeniiW23, B. subtilis subsp. inaquosorum KCTC
13429) and the type strain of a common Bacillus biocontrol species
(B. amyloliquefaciens subsp. plantarum strain FZB42) were compared
using BLAST matrix. The results (Fig. 3) conﬁrm that the phylogenetic
analysis, which showed the closest relative to B. subtilis subsp. subtilis
OH 131.1 is the biocontrol strain B. subtilis subsp. subtilis BSn5. The
strains share 90.0% of their protein-coding regions with each other,ntations. B) Subtilomycin at 9 h. EIC gray 2+ ion, red 3+ ion, blue 4+ ion (excluding intense
Fig. 2. Phylogenetic placement of OH 131.1 among other strains of B. subtilis. The tree was reconstructed from Tamura–Nei gamma distances using the NJ method; numbers at nodes
represent bootstrap percentages based on 1500 pseudoreplicates (only values greater than 50% are shown). Strains for which complete genome data were analyzed in this study are
highlighted in gray.
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with the type strain for the subspecies (B. subtilis subsp. subtilis str.
168). The protein-coding region comparisons were used to determine
if the two biocontrol strains (OH 131.1 and BSn5) had any genes
not found in the other nonbiocontrol B. subtilis strains. The resultsidentiﬁed 17 unique genes shared by the biocontrol strains (Supple-
mental Table 1). The set contained the 6 genes that make up the
subtilomycin cluster, a serine/threonine kinase, comX pheromone
precursor protein, a transcriptional regulator (merR family) and 8
hypothetical proteins.
Fig. 3. Protein-coding region comparisons between B. subtilis subsp. subtilis str. OH 131.1 and related strains using BLASTmatrix.
6 C.A. Dunlap et al. / Plant Gene 2 (2015) 1–93.5. Co-culture of Bacillus sp. OH 131.1 and C. ﬂavescens OH 182.9 3C
When cultured alone, populations (log10 cfu/ml) of B. subtilis OH
131.1 and C. ﬂavescens OH 182.9 reached 8.64 and 8.24, respectively,
after 48 h (Table 3). Populations of each component strain in the
1:100 OH 131.1:OH 182.9 co-culture were within 0.50 log unit of their
respective populations reached when cultured alone (Table 3). While
populations of OH 131.1 in the co-cultures inoculated at all the differentTable 3
Inﬂuence of co-cultures of yeast antagonist C. ﬂavescens OH 182.9 3C and bacterial strain
B. subtilis OH 131.1 inoculated at different cell ratios on Fusarium head blight in green-
house trials.x,y
Treatmentz Log10 cfu/ml of
treatment culture
at 48 h harvest
(OH 131.1/OH 182.9)
Wheat cultivar
Norm
DS (%) DI (%) 100 Kwt (g)
Untreated control NA 50A 63A 1.51A
1:100 (OH 131.1:
OH 182.9)
8.93/8.11 18CD 31D 1.78A
1:10 9.20/7.89 17D 32CD 1.65A
1:1 8.84/6.98 35ABC 55AB 1.57A
10:1 8.39/4.84 38AB 52ABC 1.66A
100:1 8.61/4.87 24BCD 37BCD 1.66A
OH 182.9 3C 8.24 24BCD 40BCD 1.74A
OH 131.1 8.64 34BCD 47ABCD 1.67A
P value 0.001 0.005 0.72
x Within a column, means not followed by the same letter are signiﬁcantly different
(P ≤ 0.05, Fisher's protected LSD).
y DS=disease severity (=average % of individual head visually diseased), DI=disease
incidence, 100 Kwt = one hundred kernel weight.
z Ratios (vol:vol) of different seed inocula, composed of a mixture of 24 h log growth
cultures of OH 131.1 and OH 182.9 3C, respectively, used to inoculate test cultures are
indicated. Test cultures were harvested after 48 h, log10 cfu/ml of each component strain
determined (representative values in the adjacent column), and the harvested cultures
applied to wheat plant heads at a rate of 25% of full strength.ratios of the two component strainswhichwere nevermore than 0.6 log
units different from that of OH 131.1 cultured alone, OH 182.9 popula-
tions dropped consistently in co-cultures as the inoculation ratio of
OH 182.9 ranged from being 100× that of OH 131.1 to being 1/100
that of OH 131.1. In the 100:1 OH 131.1:OH 182.9 co-culture, the popu-
lation of OH 182.9 was 4.87 (log10 cfu/ml), more than 3 log units lower
than when grown alone or in the 1:100 OH 131.1:OH 182.9 co-culture
(Table 3).
3.6. Efﬁcacy of co-cultures against Fusarium head blight
Cells of OH 131.1 and OH 182.9 cultured alone reduced FHB disease
severity and OH 182.9 cultured alone also reduced FHB incidence com-
pared to the control (P≤ 0.05, FPLSD, Table 3). All co-culture treatments
arithmetically reduced disease severity and all treatments signiﬁcantly
reduced disease severity except for the 1:1 and 10:1 co-cultures
(P ≤ 0.05, FPLSD, Table 3). The 1:100 and 1:10 co-cultures of OH
131.1:OH 182.9 reduced disease severity by more than any other treat-
ment (~65%) arithmetically, but were not signiﬁcantly more efﬁcacious
than the cultures of each strain grown individually. Single strain and co-
culture treatments also reduced disease incidence with all but the 1:1,
10:1 and OH 131.1 alone treatments reducing incidence signiﬁcantly
(P≤ 0.05, Fisher's protected LSD, Table 3). Though all treatments result-
ed in higher 100 kernel weights than the control, nonewere statistically
signiﬁcant (Table 3).
4. Discussion
The completed genome of B. subtilis subsp. subtilis OH 131.1 provid-
ed new insights into the potential metabolites it is capable of producing
as well as its phylogeny. The genome size, gene complement, and GC
content are consistent with those of previously published B. subtilis ge-
nomes (Becher et al., 2011; Earl et al., 2012). The analysis suggests that
the subject strain has the potential to make two antifungal molecules
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tial other antimicrobial compounds, surfactin does not have activity
against the causal agent of FHB (G. zeae) (Dunlap et al., 2011). The
spectrum of antimicrobial activity of subtilosin is primarily limited
to bacteria with strong activity against Listeria sp. (Shelburne et al.,
2007). Similarly, bacillaene is an antibiotic that is active against a
broad spectrum of bacteria (Patel et al., 1995).
The three clusters (surfactin, plipastatin, bacillibactin) that produced
trace amounts of metabolites and the single cluster (bacillaene) from
which we could not detect the metabolite are all dependent on the sfp
gene for activity. All polyketide synthases (PKSs) and non-ribosomal
peptide synthetases (NRPSs) require a posttranslational modiﬁcation to
become catalytically active (Lambalot et al., 1996). The sfp gene is a
phosphopantetheinyl transferase that transfers a 4′-phosphopantetheinyl
moiety to a conserved serine in PKS and NRPS enzyme modules
(Lambalot et al., 1996). A fatal frameshift mutation in sfp has been ob-
served in the B. subtilis type strain 168, and it does not produce surfactin
or plipastatin even though it has theNRPS clusters (Nakano et al., 1992).
Analysis of the putative sfp gene in the subject strain shows that the
gene should be functional. Analysis of 100 bp upstream of the gene
start ﬁnds the region 100% homologous with 12 B. subtilis subsp. subtilis
strain genomes (data not shown), which suggests that they all share the
samepromoter and transcription factor binding. It remains unclearwhy
these sfp-dependent clusters are not more productive under the condi-
tions tested. We have also seen sharp increases in the iron siderophore
bacillibactin production under iron starvation conditions (data not
shown) (Miethke et al., 2006), which suggests that the sfp gene is func-
tional and regulated.
Plipastatin is a known antifungal, but it was only produced in trace
amounts under these conditions and these concentrations are insufﬁ-
cient to inhibit G. zeae (Dunlap et al., 2011). It's important to note,
plipastatin and fengycin have been recently reported to be the same
molecule with a variety of potential alkyl tail isomers (Honma et al.,
2012). Production of plipastatin requires the pps genes (ppsABCDE),
the sfp gene and the pleiotropic regulator degQ (Tsuge et al., 2007).
The pps genes are functional, since small quantities (sub-nanomolar
concentrations) of plipastatin were detected. The degQ gene is present
with high homology to other known producers. It remains unclear
when this pathway is upregulated.
Subtilomycin is a recently described lantibiotic from B. subtilis strain
MMA7, which was isolated from the marine sponge Haliclona simulans
(Phelan et al., 2013). The subA gene, from the subtilomycin synthetic
cluster, was previously detected in all B. subtilis strains isolated from
different costal and deep water marine sponges (Phelan et al., 2013).
While non-marine derived strains lacked the gene when screened by
PCR or in silico genome analysis, the lone exceptionwas B. subtilis strain
BSn5, a biocontrol strain closely related to the subject strain that was
isolated from Amorphophallus konjac (Deng et al., 2011). Discovering
the cluster in the subject strain,whichwas isolated fromawheat anther,
suggests that the cluster can also be found in terrestrial plant-associated
B. subtilis strains, in addition to those isolated from marine sponges. A
BLAST search of GenBank conﬁrms that the cluster can only be found
in the genomes B. subtilis strain BSn5 and OH 131.1. Subtilomycin pro-
duction in the subject strain was temporally the same as the marine
strain. Under these conditions, concentration peaked at 9 h and declined
with time, suggesting a similar regulation.
The subtilosin clusterwas found in all 12 completed genomes and18
of 21 draft genomes for B. subtilis strains onGenBank. Subtilosin is a bac-
teriocin, one of the most common classes of antibacterials (Riley and
Wertz, 2002). Bacteriocins are thought tomediate interactions inmicro-
bial communities that overlap ecological niches (Hawlena et al., 2012).
This is based, in part, on bacteriocins often having activity against
conspeciﬁc members of the population (Riley and Wertz, 2002). This
should be an important consideration when choosing potential
co-culture candidates, since they may also have been isolated from the
same ecological niche.The results of our phylogenetic analysis show that strain OH 131.1 is
amember of B. subtilis subsp. subtilis and closely related to strains isolat-
ed from soil collected in Greenland and Ghana. Although this may seem
surprising, it is not unexpected as B. subtilis and other members of
B. subtilis species complex are distributed widely across the world
(Rooney et al., 2009). Genome-level comparisons (Fig. 3) between OH
131.1 and other B. subtilis species complex strains whose complete ge-
nomes are available identiﬁed 17 protein-coding genes shared in com-
mon between, and which are unique to, OH 131.1 and BSn5, another
biocontrol strain (Deng et al., 2011). Although BSn5 does not cluster
with OH 131.1 at a level supported by high bootstrap values (less than
50%; Fig. 2), both strains share the subtilomycin cluster, which has a
wide spectrum of antimicrobial activity (Phelan et al., 2013). Thus, it
may be worthwhile to determine the biocontrol potential of strains
that share a close phylogenetic afﬁnity with Bsn5 and OH 131.1, as
those strains might also possess the subtilomycin cluster and other ho-
mologs that may impart biocontrol activity to strains that possess them
(strains: NRRL BD-566, NRRL BD-586, NRRL BD-587 and NRRL BD-588).
The function of most of the remaining homologs is unknown, with 8
protein coding regions annotated as hypothetical protein and 2 belong-
ing to a broad class of proteins, a serine/threonine kinase and a merR
family transcriptional regulator. The merR family protein is part of a
broad class of transcriptional factors that have been associated with
the response to a variety of stresses, such as oxidative, heavy metals
or antibiotics (Brown et al., 2003). A ﬁnal homolog codes for the precur-
sor of the comX pheromone. The comX pheromone is a quorum sensing
molecule in Bacillus species, which regulates the genetic competence
pathway (Grossman, 1995) and also contributes to the ability to
form bioﬁlms (Rooney et al., 2005); either or both of these traits
could, in theory, contribute to biocontrol activity of OH 131.1 and
BSn5, although experimental conﬁrmation is needed to prove this
theory.
Co-cultures of B. subtilisOH 131.1 and C. ﬂavescensOH 182.9 initially
inoculated at a ratio of 1:100 or 1:10, respectively, were themost effec-
tive in reducing FHB symptoms compared to the control and in some
cases reduced disease to a greater extent than co-cultures inoculated
at 1:1 or 10:1 respectively (P ≤ 0.05, Fisher's protected LSD, Table 3).
The sum of cfu/ml produced by each component strain was greatest in
1:100 and 1:10 co-cultures compared to other co-cultures or each strain
cultivated alonewhich likely at least partially explains the increased ef-
ﬁcacy of the 1:100 and 1:10 co-cultures. The high total cell number in
these co-cultures could be due to the two organisms utilizing different
portions of the casein hydrolysate that would be incompletely utilized
when each strain is grown alone in the SDCL medium. Information
gained in determining the whole genome sequence of B. subtilis OH
131.1 in this study provides a means in future studies to determine if
the presence of high numbers of cells of C. ﬂavescens OH 182.9 stimu-
lates expression of genes likely involved in reducing disease such as
subtilomycin production in OH 131.1 compared to co-cultures with
lower levels of OH 182.9 cells.
Higher initial inoculum rates of OH 131.1 compared to OH 182.9 re-
sulted in ﬁnal co-cultures with greatly reduced populations of OH 182.9
while OH 131.1 populations at 48 h were within approximately 0.5 log
units of OH 131.1 cultured alone for the various co-cultures regardless
of the inoculum rates of OH 182.9 used (Table 3). In shake ﬂasks with
SDCL medium and adequate aeration, the doubling time for cells of
OH 131.1 is approximately 1 h while the doubling time for cells of OH
182.9 cell populations takes twice as long (Schisler, unpublished).
When OH 182.9 is inoculated at progressively lower ratios compared
toOH131.1, cells of OH182.9 appear to be progressively less able to rap-
idly reproduce. Subtilomycin, shown in the current study to be pro-
duced by OH 131.1, has antifungal activity and may inhibit OH 182.9
to a greater extent in those co-cultures where OH 182.9 does not
make up a large percentage of the initial co-culture inoculum. Interest-
ingly, B. subtilis can produce quorum sensing peptides that trigger cell
death in Escherichia coli (Kumar et al., 2013) and the basidiomycetous
8 C.A. Dunlap et al. / Plant Gene 2 (2015) 1–9yeast Trichosporon loubieri can degrade N-acyl-homoserine lactones
involved in bacterial quorum sensing (Wong et al., 2013). With the ge-
nome of B. subtilis OH 131.1 characterized in the present study, future
metabolomic and proteomic studies to characterize differential gene
expression in co-cultures inoculated with varying ratios of OH 131.1
and OH 182.9 should clarify the reason for differences in ﬁnal cell pop-
ulations of each strain and levels of biocontrol efﬁcacy achieved.
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doi.org/10.1016/j.plgene.2015.03.002.Acknowledgments
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